And a number of studies suggested that EGR1 exhibits prominent tumor-suppressive activity by activating major tumor suppressor factors, including transforming growth factor-β1, p53, p73, fibronectin, and PTEN [40, 41]. The gene discussed is TP53; the disease is neoplasm.